Larimar Therapeutics (LRMR) Price-to-Earnings (P/E) Ratio
Price: $2.65
Market Cap: $169.67M
Avg Volume: 858.32K
Market Cap: $169.67M
Avg Volume: 858.32K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Larimar Therapeutics's P/E ratios across different time periods:
- TTM: -2.01
- Annual: -2.94
- Quarterly: -2.06
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 1.38
- Price-to-Sales (P/S) Ratio: 0.00
Annual Ratios
Larimar Therapeutics Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-2.01
P/B Ratio (Annual)
1.38
P/S Ratio (Annual)
0.00
Larimar Therapeutics Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -2.94 | 1.38 | 0.00 |
| 2023 | -5.41 | 2.44 | 0.00 |
| 2022 | -3.11 | 0.96 | 0.00 |
| 2021 | -3.68 | 2.88 | 0.00 |
| 2020 | -6.01 | 2.84 | 0.00 |
| 2019 | -5.31 | -176.84 | 0.00 |
| 2018 | -2.60 | 1.71 | 0.00 |
| 2017 | -2.44 | 1.62 | 0.00 |
| 2016 | -1.50 | 0.71 | 0.00 |
| 2015 | -2.27 | 1.00 | 0.00 |
| 2014 | -24.45 | 8.56 | 0.00 |
| 2013 | -36.80 | 14.65 | 0.00 |
| 2012 | -37.19 | 64.07 | 0.00 |
| 2011 | -39.23 | 0.00 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for LRMR.